Condition
Puberty, Delayed
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06931912Not ApplicableRecruiting
Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia
NCT00494169Completed
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
NCT05417035Not ApplicableCompletedPrimary
Pubertal Replacement In Boys Study Nebido and Testoviron Depot Treatment
Showing all 3 trials